Astra Zeneca has put a hold on the late stage trial of its highly anticipated Covid 19 vaccine candidate after a suspected serious adverse reaction in a study participant in the UK , health news website Stat News has reported . 
It quoted an Astra Zeneca spokesperson as saying in a statement that the " standard review process triggered a pause to vaccination to allow review of safety data " . 
